US Patent Issued to Janssen Biotech on April 8 for "Antigen binding regions against fibronectin type III domains and methods of using the same" (Pennsylvania, California Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,269,870, issued on April 8, was assigned to Janssen Biotech Inc. (Horsham, Pa.).

"Antigen binding regions against fibronectin type III domains and methods of using the same" was invented by Chichi Huang (Malvern, Pa.), John Lee (Ambler, Pa.), Jill Mooney (San Diego) and Michael Naso (Swarthmore, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Fibronectin type III (FN3) domain antibodies, polynucleotides capable of encoding the FN3 domain antibodies or antigen-binding fragments, cells expressing FN3 domain antibodies or antigen-binding fragments, as well as associated vectors and detectably labeled FN3 domain antibodies or antigen-binding fragments ma...